
Matrix-derived serum markers in monitoring liver fibrosis in children with chronic hepatitis B treated with interferon alpha
Author(s) -
Dariusz Marek Lebensztejn,
M Sobaniec-Łotowska,
M Kaczmarski,
Michael Voelker,
Detlef Schuppan
Publication year - 2006
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v12.i21.3338
Subject(s) - fibrosis , medicine , gastroenterology , inflammation , alpha interferon , tenascin , pathology , interferon , immunology , extracellular matrix , biology , fibronectin , microbiology and biotechnology
To evaluate prospectively 4 selected serum fibrosis markers (tenascin, hyaluronan, collagen VI, TIMP-1) before, during and 12 mo after IFN treatment of children with chronic hepatitis B.